Prostate-specific antigen doubling time as a predictor of prostate cancer disease progression and survival

Autor:	Joel B. Nelson, D. S. Sleep, S. M. Hulting, A. R. Allen, Jeffrey D. Isaacson
Rok vydání:	2004
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Atrasentan Disease progression medicine.disease Prostate-specific antigen Prostate cancer Antigen Internal medicine medicine Doubling time Receptor business Endothelin a medicine.drug
Zdroj:	Journal of Clinical Oncology. 22:4554-4554
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2004.22.90140.4554
Popis:	4554 Background: Prostate-specific antigen doubling time (PSADT) has been identified as a predictor of outcome in prostate cancer. Atrasentan, a potent, selective, oral endothelin A receptor antago...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::95328623933ca2ee87ad1c72eb0d06a2 https://doi.org/10.1200/jco.2004.22.90140.4554 Zobrazit plný text záznamu